In this Issue:
Dose-dense adjuvant chemotherapy improves survival
Omitting radiotherapy is an option in some older women
. . . but many continue to receive radiotherapy
Is chemotherapy always needed for HER2+ disease?
Eribulin vs capecitabine in metastatic breast cancer
Early detection of metastatic breast cancer
Persistent docetaxel-induced neuropathy
5 years of tamoxifen for prevention: long-term effectiveness
WBRT ± temozolomide for brain metastases from breast cancer
Aspirin use and survival in breast cancer
Please login below to download this issue (PDF)